Clinical Trial Update: Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 efficacy trial of folinic acid for improving mental development in children with Down syndrome. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Folinic acid (folinic acid)

Snippet

Sponsor: Institut Jerome Lejeune | Conditions: Down Syndrome | Phase 2, Phase 3 | Status: COMPLETED